 CANTON, Mass., May 10, 2021 GLOBE NEWSWIRE -- Organogenesis Holdings Inc. Nasdaq: ORGO, a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical Sports Medicine markets, today announced the appointment of Jon Giacomin to the Companys Board of Directors, effective May 7, 2021. The Company also announced that Wayne Mackie resigned as a member of the Companys Board of Directors effective May 7, 2021. Mr. Mackies resignation was not due to any disagreement with the Company on any matter relating to its operations, policies or practices. 